Upharmacia October 2017
PHARMA MARKET NEWS
Indar will Establish Joint Enterprise in Azerbaijan
Indar , the Ukrainian producer of insulin , has signed the Memorandum with Azerbaijani Investment Company on establishing a joint pharmaceutical venture in Pirallahy Industrial Park . The company will produce infusion and injection solutions . The construction of production facilities will start in 2018 and will last for 2 years . The cost of the project is to amount USD 17 mio . The enterprise will create 350 jobs .
Pirallahy Industrial Park was created in 2016 following the President ’ s Order to promote the development of the local pharmaceutical industry . Currently , 3 companies are constructing facilities in the Park . The residents of the Park are freed from paying different taxes for 7 years .
Indar was established in 1997 by the government . 70 % of the company belongs to the State company Ukrmedprom . The company is included in the list of state objects , which have a strategic importance for the economy and state security .
BCPP Plans to Launch 4-6 New
Drugs by the end of 2017
Borshchahivskiy Chemical-Pharmaceutical Plant ( BCCP ) plans to launch onto the market from 4 to 6 new drugs by the year-end , the company ’ s reconstruction and development Director sated . The preparations are related to cardiovascular diseases and neurology . Currently , BCPP has about 25 drugs in development .
The market of cardio drugs amounted about UAH 7,1 bn in 2016 . In 9M 2017 , BCCP was 20 th company on Ukrainian drug market by sales . In 2016 , the company doubled its net profit vs 2015 to UAH 118.7 mio .
Galychpharm
Received GMP
Certificate to Produce Tablets
Galychpharm company received Ukrainian GMP certificate to produce drugs in form of tablets . Lately , the company reconstructed the tablet-packing shop and installed more than 14 units of new equipment . Galychpharm is a producer of about 90 herbal-based drugs and phyto-chemical substances . Some of is drugs are produced in a form of tablets , such as Mucaltine , Streptocide , Asparkam etc .
Galychpharm is a Lviv-based part of Arterium Corporation , which also includes Kyivmedpreparat company . In 9M 2017 , Arterium corporation held the second place on the Ukrainian drugs market by retail sales .
Lekhim Launches Veterinary Direction
Lekhim group of companies started producing veterinary drugs on the base of Technolog company . Thus , the company , the main focus of which are cardiology and drugs for alimentary tract , opened the new direction of its development . Lekhim started developing the veterinary direction in 2016 and now has 3 veterinary drugs to produce .
Lekhim group includes JSC Lekhim ( Kyiv ), JSC Technolog ( Uman ) and JSC Lekhim-Kharkiv ( Kharkiv ). In Oct 2017 , Technolog plant received the EU GMP certificate to produce drugs .
Darnitsa Increased its Net Profits
Pharmaceutical Firm Darnitsa increased its net profits by 5 % in 3Q 2017 vs the same period in 2016 to UAH 252.3 mio .
Gross profit for the same period grew by 19 % to UAH 998.6 mio , NSSMC stated .
The company was the third largest local manufacturer in 2016 following Farmak and Arterium .
More Than 70 % of Medicines Bought Directly From Suppliers
The UNDP has analyzed the procurement it conducted with the funds of 2016 state budget .
According to the results , share of medicines bought directly from manufacturers comprised 71 %, in contrast to 90 % of the MoH tenders won by distributors in 2014 and earlier years - before the international procurement of medicines was introduced .
6 www . upharma-c . com